These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 8445603)

  • 21. Goserelin treatment in glandular hyperplasia.
    Garozzo G; La Greca M; Lomeo E; Panella M
    Clin Exp Obstet Gynecol; 1993; 20(4):268-72. PubMed ID: 8281712
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A randomised controlled trial comparing the Cavaterm endometrial ablation system with the Nd:YAG laser for the treatment of dysfunctional uterine bleeding.
    Hawe J; Abbott J; Hunter D; Phillips G; Garry R
    BJOG; 2003 Apr; 110(4):350-7. PubMed ID: 12699795
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Supplementing iron intravenously in pregnancy. A way to avoid blood transfusions.
    Hallak M; Sharon AS; Diukman R; Auslender R; Abramovici H
    J Reprod Med; 1997 Feb; 42(2):99-103. PubMed ID: 9058345
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Does preoperative treatment with a gonadotropin-releasing hormone agonist improve the outcome of endometrial resection?
    Vercellin P; Perin A; Consonn R; Oldan S; Parazzini F; Crosignani PG
    J Am Assoc Gynecol Laparosc; 1998 Nov; 5(4):357-60. PubMed ID: 9782138
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effectiveness and tolerance of a gonadotropin releasing hormone (goserelin) in treatment of symptomatic endometriosis].
    Wenzl R; Schultes G; Stummvoll W; Wieser F; Husslein P
    Wien Klin Wochenschr; 1999 Apr; 111(7):283-8. PubMed ID: 10355039
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Iron protein succinylate in the treatment of iron deficiency: controlled, double-blind, multicenter clinical trial on over 1,000 patients.
    Liguori L
    Int J Clin Pharmacol Ther Toxicol; 1993 Mar; 31(3):103-23. PubMed ID: 8468108
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The use of GnRH agonists in severe uterine hemorrhages in adolescence caused by congenital aplastic and hypoplastic anemias].
    Nikolov A; Bŭrdarova I; Kolarov G; Veltova L
    Akush Ginekol (Sofiia); 1999; 38(2):46-8. PubMed ID: 10730389
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gonadal protection by a gonadotropin-releasing hormone agonist depot in young women with Hodgkin's disease undergoing chemotherapy.
    Franke HR; Smit WM; Vermes I
    Gynecol Endocrinol; 2005 May; 20(5):274-8. PubMed ID: 16019373
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Decreased treatment failure rates following duodenal release ferrous glycine sulfate in iron deficiency anemia associated with autoimmune gastritis and Helicobacter pylori gastritis.
    Hershko C; Ianculovich M; Souroujon M
    Acta Haematol; 2007; 118(1):19-26. PubMed ID: 17426393
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Determining dosing intervals for luteinizing hormone releasing hormone agonists based on serum testosterone levels: a prospective study.
    Pathak AS; Pacificar JS; Shapiro CE; Williams SG
    J Urol; 2007 Jun; 177(6):2132-5; discussion 2135. PubMed ID: 17509298
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Psychiatric manifestations of vitamin B12 deficiency: a case report].
    Durand C; Mary S; Brazo P; Dollfus S
    Encephale; 2003; 29(6):560-5. PubMed ID: 15029091
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of intravenous ascorbic acid in hemodialysis patients with EPO-hyporesponsive anemia and hyperferritinemia.
    Attallah N; Osman-Malik Y; Frinak S; Besarab A
    Am J Kidney Dis; 2006 Apr; 47(4):644-54. PubMed ID: 16564942
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Severe anemia from heavy menstrual bleeding requires heightened attention.
    Nelson AL; Ritchie JJ
    Am J Obstet Gynecol; 2015 Jul; 213(1):97.e1-97.e6. PubMed ID: 25935784
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of a levonorgestrel-releasing intrauterine device for the symptomatic treatment of uterine myomas.
    Rosa e Silva JC; de Sá Rosa e Silva AC; Cândido dos Reis FJ; Manetta LA; Ferriani RA; Nogueira AA
    J Reprod Med; 2005 Aug; 50(8):613-7. PubMed ID: 16220768
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Levonorgestrel-releasing intrauterine device versus hysteroscopic endometrial resection in the treatment of dysfunctional uterine bleeding.
    Crosignani PG; Vercellini P; Mosconi P; Oldani S; Cortesi I; De Giorgi O
    Obstet Gynecol; 1997 Aug; 90(2):257-63. PubMed ID: 9241305
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Subcutaneous epoetin-alpha every one, two, and three weeks in renal anemia.
    Piccoli A; Malagoli A; Komninos G; Pastori G
    J Nephrol; 2002; 15(5):565-74. PubMed ID: 12455725
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [A new LH-RH agonist for treatment of prostate cancer, 3-month controlled-release formulation of goserelin acetate (Zoladex LA 10.8 mg depot)--outline of pre-clinical and clinical studies].
    Tsukagoshi S
    Gan To Kagaku Ryoho; 2002 Sep; 29(9):1675-87. PubMed ID: 12355959
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Short-term use of Goserelin depot in the treatment of dysfunctional uterine bleeding.
    Colacurci N; De Placido G; Mollo A; Perino A; Cittadini E
    Clin Exp Obstet Gynecol; 1995; 22(3):212-9. PubMed ID: 7554259
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Proposed therapeutic algorithm for the treatment of anemia of chronic renal failure in pre-dialysis patients with low dose once weekly subcutaneous r-HuEPO. Multicenter Study Group, Israel.
    Yagil Y
    Isr J Med Sci; 1997 Jan; 33(1):36-44. PubMed ID: 9203516
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The management of severe anemia due to iron deficiency and benign gynecologic disease.
    Pritchard JA
    Am J Obstet Gynecol; 1965 Nov; 93(5):617-31. PubMed ID: 4284856
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.